Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 590808, 13 pages
http://dx.doi.org/10.1155/2014/590808
Review Article

Thioredoxin System Regulation in the Central Nervous System: Experimental Models and Clinical Evidence

1Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, 14269 México City, DF, Mexico
2Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510 México City, DF, Mexico
3Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 México City, DF, Mexico

Received 11 October 2013; Revised 21 January 2014; Accepted 23 January 2014; Published 27 February 2014

Academic Editor: Sathyasaikumar V. Korrapati

Copyright © 2014 Daniela Silva-Adaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. C. Laurent, E. C. Moore, and P. Reichard, “Enzymatic synthesis of deoxyribonucleotides. IV. isolation and characterization of thioredoxin, the hydrogen donor from escherichia coli B,” The Journal of Biological Chemistry, vol. 239, pp. 3436–3444, 1964. View at Google Scholar · View at Scopus
  2. H. Z. Chae, H. J. Kim, S. W. Kang, and S. G. Rhee, “Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 101–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. C. H. Lillig and A. Holmgren, “Thioredoxin and related molecules—from biology to health and disease,” Antioxidants and Redox Signaling, vol. 9, no. 1, pp. 25–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Burke-Gaffney, M. E. J. Callister, and H. Nakamura, “Thioredoxin: friend or foe in human disease?” Trends in Pharmacological Sciences, vol. 26, no. 8, pp. 398–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. J. Arnér and A. Holmgren, “Physiological functions of thioredoxin and thioredoxin reductase,” European Journal of Biochemistry, vol. 267, no. 20, pp. 6102–6109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Pekkari and A. Holmgren, “Truncated thioredoxin: physiological functions and mechanism,” Antioxidants and Redox Signaling, vol. 6, no. 1, pp. 53–61, 2004. View at Google Scholar · View at Scopus
  7. R. B. Carilho Torrao, I. H. Dias, S. J. Bennett, C. R. Dunston, and H. R. Griffiths, “Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion,” Chemistry Central Journal, vol. 7, no. 1, p. 150, 2013. View at Google Scholar
  8. J. Nordberg and E. S. J. Arnér, “Reactive oxygen species, antioxidants, and the mammalian thioredoxin system,” Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1287–1312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. X. S. Zeng, J. J. Jia, Y. Kwon, S. D. Wang, and J. Bai, “The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease,” Free Radical Biology & Medicine, vol. 67, pp. 10–18, 2013. View at Google Scholar
  10. A. Holmgren and M. Luthman, “Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay,” Biochemistry, vol. 17, no. 19, pp. 4071–4077, 1978. View at Google Scholar · View at Scopus
  11. J. Soerensen, C. Jakupoglu, H. Beck et al., “The role of thioredoxin reductases in brain development,” PLoS ONE, vol. 3, no. 3, Article ID e1813, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. B. Jornstedt, S. Kumar, and A. Holmgren, “Selenite and selenodiglutathione: reactions with thioredoxin systems,” Methods in Enzymology, vol. 252, pp. 209–219, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Zhong, E. S. J. Arnér, and A. Holmgren, “Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 5854–5859, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Lundstrom and A. Holmgren, “Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity,” Journal of Biological Chemistry, vol. 265, no. 16, pp. 9114–9120, 1990. View at Google Scholar · View at Scopus
  15. J. M. May, S. Mendiratta, K. E. Hill, and R. F. Burk, “Reduction of dehydroascorbate to ascotbate by the selenoenzyme thioredoxin reductase,” Journal of Biological Chemistry, vol. 272, no. 36, pp. 22607–22610, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. May, C. E. Cobb, S. Mendiratta, K. E. Hill, and R. F. Burk, “Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase,” Journal of Biological Chemistry, vol. 273, no. 36, pp. 23039–23045, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. E. S. J. Arnér, J. Nordberg, and A. Holmgren, “Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase,” Biochemical and Biophysical Research Communications, vol. 225, no. 1, pp. 268–274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Xia, M. Björnstedt, T. Nordman, L. C. Eriksson, and J. M. Olsson, “Reduction of ubiquinone by lipoamide dehydrogenase: an antioxidant regenerating pathway,” European Journal of Biochemistry, vol. 268, no. 5, pp. 1486–1490, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Dringen, J. M. Gutterer, and J. Hirrlinger, “Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species,” European Journal of Biochemistry, vol. 267, no. 16, pp. 4912–4916, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Rozell, H.-A. Hansson, M. Luthman, and A. Holmgren, “Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats,” European Journal of Cell Biology, vol. 38, no. 1, pp. 79–86, 1985. View at Google Scholar · View at Scopus
  21. S. Stemme, H.-A. Hansson, A. Holmgren, and B. Rozell, “Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve,” Brain Research, vol. 359, no. 1-2, pp. 140–146, 1985. View at Google Scholar · View at Scopus
  22. H. Tomimoto, I. Akiguchi, H. Wakita, J. Kimura, K. Hori, and J. Yodoi, “Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia,” Brain Research, vol. 625, no. 1, pp. 1–8, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Asahina, T. Yamada, Y. Yoshiyama, and J. Yodoi, “Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues,” Dementia and Geriatric Cognitive Disorders, vol. 9, no. 4, pp. 181–185, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Godoy, M. Funke, W. Ackermann et al., “Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse,” Biochimica et Biophysica Acta, vol. 1810, no. 1, pp. 2–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Lippoldt, C. A. Padilla, H. Gerst et al., “Localization of thioredoxin in the rat brain and functional implications,” Journal of Neuroscience, vol. 15, no. 10, pp. 6747–6756, 1995. View at Google Scholar · View at Scopus
  26. M. L. Aon-Bertolino, J. I. Romero, P. Galeano et al., “Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system,” Biochimica et Biophysica Acta, vol. 1810, no. 1, pp. 93–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Rybnikova, A. E. Damdimopoulos, J.-Å. Gustafsson, G. Spyrou, and M. Pelto-Huikko, “Expression of novel antioxidant thioredoxin-2 in the rat brain,” European Journal of Neuroscience, vol. 12, no. 5, pp. 1669–1678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Rubartelli, A. Bajetto, G. Allavena, E. Wollman, and R. Sitia, “Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway,” Journal of Biological Chemistry, vol. 267, no. 34, pp. 24161–24164, 1992. View at Google Scholar · View at Scopus
  29. F. Gil-Bea, S. Akterin, T. Persson et al., “Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain,” EMBO Molecular Medicine, vol. 4, no. 10, pp. 1097–1111, 2012. View at Google Scholar
  30. K. Pekkari, M. T. Goodarzi, A. Scheynius, A. Holmgren, and J. Avila-Cariño, “Truncated thioredoxin (Trx80) induces differentiation of human CD14 + monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK,” Blood, vol. 105, no. 4, pp. 1598–1605, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Wakasugi, Y. Tagaya, H. Wakasugi et al., “Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8282–8286, 1990. View at Google Scholar · View at Scopus
  32. D. Schubert, F. Herrera, R. Cumming et al., “Neural cells secrete a unique repertoire of proteins,” Journal of Neurochemistry, vol. 109, no. 2, pp. 427–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. LoPachin and D. S. Barber, “Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants,” Toxicological Sciences, vol. 94, no. 2, pp. 240–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Hori, M. Katayama, N. Sato, K. Ishii, S. Waga, and J. Yodoi, “Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX),” Brain Research, vol. 652, no. 2, pp. 304–310, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. E. S. J. Arnér, “Focus on mammalian thioredoxin reductases—important selenoproteins with versatile functions,” Biochimica et Biophysica Acta, vol. 1790, no. 6, pp. 495–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Bindoli and M. P. Rigobello, “Principles in: from chemistry to functional significance,” Redox SignalingAntioxidants & Redox Signaling, vol. 18, no. 13, pp. 1557–1593, 2013. View at Google Scholar
  37. K. Hirota, H. Nakamura, H. Masutani, and J. Yodoi, “Thioredoxin superfamily and thioredoxin-inducing agents,” Annals of the New York Academy of Sciences, vol. 957, pp. 189–199, 2002. View at Google Scholar · View at Scopus
  38. M. A. Lovell, C. Xie, S. P. Gabbita, and W. R. Markesbery, “Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain,” Free Radical Biology and Medicine, vol. 28, no. 3, pp. 418–427, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Takagi, F. Horikawa, K. Nozaki, T. Sugino, N. Hashimoto, and J. Yodoi, “Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat,” Neuroscience Letters, vol. 251, no. 1, pp. 25–28, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Takagi, A. Mitsui, A. Nishiyama et al., “Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 7, pp. 4131–4136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Mansur, Y. Iwahashi, S. Kiryu-Seo et al., “Up-regulation of thioredoxin expression in motor neurons after nerve injury,” Molecular Brain Research, vol. 62, no. 1, pp. 86–91, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Hattori, Y. Takagi, H. Nakamura et al., “Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice,” Antioxidants and Redox Signaling, vol. 6, no. 1, pp. 81–87, 2004. View at Google Scholar · View at Scopus
  43. T. Sugino, K. Nozaki, Y. Takagi, I. Hattori, N. Hashimoto, and J. Yodoi, “Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain,” Neuroscience Letters, vol. 275, no. 2, pp. 145–148, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. F.-A. Pitten, A. Kramer, K. Herrmann, J. Bremer, and S. Koch, “Formaldehyde neurotoxicity in animal experiments,” Pathology Research and Practice, vol. 196, no. 3, pp. 193–198, 2000. View at Google Scholar · View at Scopus
  45. F.-C. Luo, J. Zhou, T. Lv et al., “Induction of endoplasmic reticulum stress and the modulation of thioredoxin-1 in formaldehyde-induced neurotoxicity,” NeuroToxicology, vol. 33, no. 3, pp. 290–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. H. S. Smith, “The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: a novel theory,” Pain Physician, vol. 13, no. 1, pp. 79–90, 2010. View at Google Scholar · View at Scopus
  47. F. C. Luo, Y. M. Feng, L. Zhao et al., “Thioredoxin-1 expression regulated by morphine in SH-SY5Y cells,” Neuroscience Letters, vol. 523, no. 1, pp. 50–55, 2012. View at Google Scholar
  48. K. M. Denny Joseph and M. Muralidhara, “Fish oil prophylaxis attenuates rotenone-induced oxidative impairments and mitochondrial dysfunctions in rat brain,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1529–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Eftekharpour, A. Holmgren, and B. H. Juurlink, “Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons,” Glia, vol. 31, no. 3, pp. 241–248, 2000. View at Google Scholar
  50. S. Y. Lee, T. Andoh, D. L. Murphy, and C. C. Chiueh, “17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection,” The FASEB Journal, vol. 17, no. 8, pp. 947–948, 2003. View at Google Scholar · View at Scopus
  51. U. Bardullas, J. H. Limón-Pacheco, M. Giordano, L. Carrizales, M. S. Mendoza-Trejo, and V. M. Rodríguez, “Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice,” Toxicology and Applied Pharmacology, vol. 239, no. 2, pp. 169–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Heimfarth, S. O. Loureiro, K. P. Reis et al., “Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats,” Archives of Toxicology, vol. 86, no. 2, pp. 217–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Comparsi, D. F. Meinerz, J. L. Franco et al., “Diphenyl ditelluride targets brain selenoproteins in vivo: inhibition of cerebral thioredoxin reductase and glutathione peroxidase in mice after acute exposure,” Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 173–182, 2012. View at Google Scholar
  54. T. W. Clarkson and L. Magos, “The toxicology of mercury and its chemical compounds,” Critical Reviews in Toxicology, vol. 36, no. 8, pp. 609–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Branco, J. Canário, J. Lu, A. Holmgren, and C. Carvalho, “Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase,” Free Radical Biology and Medicine, vol. 52, no. 4, pp. 781–793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Patenaude, M. R. V. Murthy, and M.-E. Mirault, “Emerging roles of thioredoxin cycle enzymes in the central nervous system,” Cellular and Molecular Life Sciences, vol. 62, no. 10, pp. 1063–1080, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Tanaka, Y. Ikeda, Y. Ohta et al., “Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion,” Brain Research, vol. 1370, pp. 246–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Tanito, M.-P. Agbaga, and R. E. Anderson, “Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro,” Free Radical Biology and Medicine, vol. 42, no. 12, pp. 1838–1850, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nakaso, H. Yano, Y. Fukuhara, T. Takeshima, K. Wada-Isoe, and K. Nakashima, “PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells,” FEBS Letters, vol. 546, no. 2-3, pp. 181–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. P. D. Maldonado, V. Pérez-De la Cruz, M. Torres-Ramos et al., “Selenium-induced antioxidant protection recruits modulation of thioredoxin reductase during excitotoxic/pro-oxidant events in the rat striatum,” Neurochemistry International, vol. 61, no. 2, pp. 195–206, 2012. View at Google Scholar
  61. T.-Y. Chen, K.-L. Tsai, T.-Y. Lee, C. C. Chiueh, W.-S. Lee, and C. Hsu, “Sex-specific role of thioredoxin in neuroprotection against iron-induced brain injury conferred by estradiol,” Stroke, vol. 41, no. 1, pp. 160–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Zhao, Z.-N. Huang, G. Chen, and J.-S. Cheng, “Electro-acupuncture attenuates nitric oxide release from rat striatum after transient middle cerebral artery occlusion,” Acupuncture and Electro-Therapeutics Research, vol. 25, no. 2, pp. 101–107, 2000. View at Google Scholar · View at Scopus
  63. F. K. W. Siu, S. C. L. Lo, and M. C. P. Leung, “Electro-acupuncture potentiates the disulphide-reducing activities of thioredoxin system by increasing thioredoxin expression in ischemia-reperfused rat brains,” Life Sciences, vol. 77, no. 4, pp. 386–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Andoh, P. Boon Chock, D. L. Murphy, and C. C. Chiueh, “Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl,” Molecular Pharmacology, vol. 68, no. 5, pp. 1408–1414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. M. L. Garcia and D. W. Cleveland, “Going new places using an old MAP: tau, microtubules and human neurodegenerative disease,” Current Opinion in Cell Biology, vol. 13, no. 1, pp. 41–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. L. M. Landino, T. E. Skreslet, and J. A. Alston, “Cysteine oxidation of tau and microtubule-associated protein-2 by peroxynitrite: modulation of microtubule assembly kinetics by the thioredoxin reductase system,” Journal of Biological Chemistry, vol. 279, no. 33, pp. 35101–35105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. H. C. Hawkins, E. C. Blackburn, and R. B. Freedman, “Comparison of the activities of protein disulphide-isomerase and thioredoxin in catalysing disulphide isomerization in a protein substrate,” Biochemical Journal, vol. 275, part 2, pp. 349–353, 1991. View at Google Scholar · View at Scopus
  68. A. Mitsui, T. Hirakawa, and J. Yodoi, “Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin,” Biochemical and Biophysical Research Communications, vol. 186, no. 3, pp. 1220–1226, 1992. View at Google Scholar · View at Scopus
  69. Y. Takagi, I. Hattori, K. Nozaki et al., “Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 5, pp. 829–833, 2000. View at Google Scholar · View at Scopus
  70. L. Kong, M. Tanito, Z. Huang et al., “Delay of photoreceptor degeneration in tubby mouse by sulforaphane,” Journal of Neurochemistry, vol. 101, no. 4, pp. 1041–1052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Kong, X. Zhou, F. Li, J. Yodoi, J. McGinnis, and W. Cao, “Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice,” Neurobiology of Disease, vol. 38, no. 3, pp. 446–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Bai, H. Nakamura, I. Hattori, M. Tanito, and J. Yodoi, “Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells,” Neuroscience Letters, vol. 321, no. 1-2, pp. 81–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. S. B. Hee, W. C. Eun, S. K. Jin et al., “Thioredoxin overexpression in HT-1080 cells induced cellular senescence and sensitization to gamma radiation,” FEBS Letters, vol. 579, no. 19, pp. 4055–4062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Munemasa, H. K. Seok, H. A. Jae, J. M. K. Kwong, J. Caprioli, and N. Piri, “Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress,” Investigative Ophthalmology and Visual Science, vol. 49, no. 8, pp. 3535–3543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Chen, M. Yu, D. P. Jones, J. T. Greenamyre, and J. Cai, “Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells,” Toxicology and Applied Pharmacology, vol. 216, no. 2, pp. 256–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Nakamura, H. Nakamura, T. Hoshino, S. Ueda, H. Wada, and J. Yodoi, “Redox regulation of lung inflammation by thioredoxin,” Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 60–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. H. Ma, N. Su, X. D. Chao et al., “Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative/nitrative stress,” Neurochemistry International, vol. 60, no. 5, pp. 475–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Zhou, P. P. Liu, G. Y. Ying, X. D. Zhu, H. Shen, and G. Chen, “Effects of thioredoxin-1 on neurogenesis after brain ischemia/reperfusion injury,” CNS Neuroscience & Therapeutics, vol. 19, no. 3, pp. 204–205, 2013. View at Google Scholar
  79. S. A. Stroev, T. S. Gluschenko, E. I. Tjulkova et al., “Preconditioning enhances the expression of mitochondrial antioxidant thioredoxin-2 in the forebrain of rats exposed to severe hypobaric hypoxia,” Journal of Neuroscience Research, vol. 78, no. 4, pp. 563–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. S. A. Stroev, E. I. Tjulkova, T. S. Gluschenko, E. A. Rybnikova, M. O. Samoilov, and M. Pelto-Huikko, “The augmentation of brain thioredoxin-1 expression after severe hypobaric hypoxia by the preconditioning in rats,” Neuroscience Letters, vol. 370, no. 2-3, pp. 224–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Andoh, P. Boon Chock, and C. C. Chiueh, “The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells,” Journal of Biological Chemistry, vol. 277, no. 12, pp. 9655–9660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. A. P. Kudin, B. Augustynek, A. K. Lehmann, R. Kovács, and W. S. Kunz, “The contribution of thioredoxin-2 reductase and glutathione peroxidase to H2O2 detoxification of rat brain mitochondria,” Biochimica et Biophysica Acta, vol. 1817, no. 10, pp. 1901–1906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Uhlig and A. Wendel, “The physiological consequences of glutathione variations,” Life Sciences, vol. 51, no. 14, pp. 1083–1094, 1992. View at Google Scholar · View at Scopus
  84. K. C. Das and C. W. White, “Detection of thioredoxin in human serum and biological samples using a sensitive sandwich ELISA with digoxigenin-labeled antibody,” Journal of Immunological Methods, vol. 211, no. 1-2, pp. 9–20, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Andoh, C. C. Chiueh, and P. B. Chock, “Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis,” Journal of Biological Chemistry, vol. 278, no. 2, pp. 885–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. I. K. Hwang, K.-Y. Yoo, D. W. Kim et al., “Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage,” Free Radical Biology and Medicine, vol. 48, no. 9, pp. 1242–1251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Gao, Z.-R. Zhu, H.-Q. Ding, Z. Qian, L. Zhu, and Y. Ke, “Vulnerability of neurons with mitochondrial dysfunction to oxidative stress is associated with down-regulation of thioredoxin,” Neurochemistry International, vol. 50, no. 2, pp. 379–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Matsui, M. Oshima, H. Oshima et al., “Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene,” Developmental Biology, vol. 178, no. 1, pp. 179–185, 1996. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Tanaka, F. Hosoi, Y. Yamaguchi-Iwai et al., “Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis,” The EMBO Journal, vol. 21, no. 7, pp. 1695–1703, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Nonn, R. R. Williams, R. P. Erickson, and G. Powis, “The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice,” Molecular and Cellular Biology, vol. 23, no. 3, pp. 916–922, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Yoshioka, E. R. Schreiter, and R. T. Lee, “Role of thioredoxin in cell growth through interactions with signaling molecules,” Antioxidants and Redox Signaling, vol. 8, no. 11-12, pp. 2143–2151, 2006. View at Google Scholar · View at Scopus
  92. E. J. Huang and L. F. Reichardt, “Neurotrophins: roles in neuronal development and function,” Annual Review of Neuroscience, vol. 24, pp. 677–736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Bai, H. Nakamura, Y.-W. Kwon et al., “Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells,” Journal of Neuroscience, vol. 23, no. 2, pp. 503–509, 2003. View at Google Scholar · View at Scopus
  94. H. Masutani, J. Bai, Y.-C. Kim, and J. Yodoi, “Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection,” Molecular Neurobiology, vol. 29, no. 3, pp. 229–242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Impey, K. Obrietan, S. T. Wong et al., “Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation,” Neuron, vol. 21, no. 4, pp. 869–883, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Endoh, T. Kunishita, and T. Tabita, “Thioredoxin from activated macrophages as a trophic factor for central cholinergic neurons in vitro,” Biochemical and Biophysical Research Communications, vol. 192, no. 2, pp. 760–765, 1993. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Y. Hui, S. S. Sheth, J. M. Diffley et al., “Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24387–24393, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. J. S. Bodnar, A. Chatterjee, L. W. Castellani et al., “Positional cloning of the combined hyperlipidemia gene Hyplip1,” Nature Genetics, vol. 30, no. 1, pp. 110–116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. S.-I. Oka, W. Liu, H. Masutani et al., “Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome,” The FASEB Journal, vol. 20, no. 1, pp. 121–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Lappalainen, J. Lappalainen, N. K. J. Oksala et al., “Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain,” Journal of Applied Physiology, vol. 106, no. 2, pp. 461–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Nishiyama, H. Masutani, H. Nakamura, Y. Nishinaka, and J. Yodoi, “Redox regulation by thioredoxin and thioredoxin-binding proteins,” IUBMB Life, vol. 52, no. 1-2, pp. 29–33, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. G. S. Kim, J. E. Jung, P. Narasimhan, H. Sakata, and P. H. Chan, “Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice,” Neurobiology of Disease, vol. 46, no. 2, pp. 440–449, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. M. M. H. Al-Gayyar, M. A. Abdelsaid, S. Matragoon, B. A. Pillai, and A. B. El-Remessy, “Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity,” British Journal of Pharmacology, vol. 164, no. 1, pp. 170–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. M. F. Rahman, J. Wang, T. A. Patterson et al., “Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles,” Toxicology Letters, vol. 187, no. 1, pp. 15–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. G. E. Hardingham and H. Bading, “Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders,” Nature Reviews Neuroscience, vol. 11, no. 10, pp. 682–696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. A. C. Rego and C. R. Oliveira, “Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases,” Neurochemical Research, vol. 28, no. 10, pp. 1563–1574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Papadia, F. X. Soriano, F. Léveillé et al., “Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses,” Nature Neuroscience, vol. 11, no. 4, pp. 476–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative diseases and oxidatives stress,” Nature Reviews Drug Discovery, vol. 3, no. 3, pp. 205–214, 2004. View at Google Scholar · View at Scopus
  109. Z. S. Khachaturian, “Diagnosis of Alzheimer's disease,” Archives of Neurology, vol. 42, no. 11, pp. 1097–1105, 1985. View at Google Scholar · View at Scopus
  110. W. R. Markesbery, “Oxidative stress hypothesis in Alzheimer's disease,” Free Radical Biology and Medicine, vol. 23, no. 1, pp. 134–147, 1997. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Akterin, R. F. Cowburn, A. Miranda-Vizuete et al., “Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease,” Cell Death and Differentiation, vol. 13, no. 9, pp. 1454–1465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. F. di Domenico, R. Sultana, G. F. Tiu et al., “Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease,” Brain Research, vol. 1333, pp. 72–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. S. Ancoli-Israel, B. W. Palmer, J. R. Cooke et al., “Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study,” Journal of the American Geriatrics Society, vol. 56, no. 11, pp. 2076–2081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. X. H. Yang, H. G. Liu, X. Liu, and J. N. Chen, “Thioredoxin and impaired spatial learning and memory in the rats exposed to intermittent hypoxia,” Chinese Medical Journal, vol. 125, no. 17, pp. 3074–3080, 2012. View at Google Scholar
  115. J. J. Song and Y. J. Lee, “Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of appptosis signal-regulating kinase 1,” Biochemical Journal, vol. 373, part 3, pp. 845–853, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. H. Kadowaki, H. Nishitoh, F. Urano et al., “Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation,” Cell Death and Differentiation, vol. 12, no. 1, pp. 19–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. D. A. Butterfield and D. Boyd-Kimball, “The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity,” Biochimica et Biophysica Acta, vol. 1703, no. 2, pp. 149–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. Q.-A. Sun, Y. Wu, F. Zappacosta et al., “Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases,” Journal of Biological Chemistry, vol. 274, no. 35, pp. 24522–24530, 1999. View at Publisher · View at Google Scholar · View at Scopus
  119. S. P. Gabbita, M. Y. Aksenov, M. A. Lovell, and W. R. Markesbery, “Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain,” Journal of Neurochemistry, vol. 73, no. 4, pp. 1660–1666, 1999. View at Publisher · View at Google Scholar · View at Scopus
  120. F. Lamoke, G. Ripandelli, S. Webster et al., “Loss of thioredoxin function in retinas of mice overexpressing amyloid beta,” Free Radical Biology & Medicine, vol. 53, no. 3, pp. 577–588, 2012. View at Google Scholar
  121. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression, and mortality. 1967,” Neurology, vol. 57, no. 10, supplement3, pp. S11–S26, 2001. View at Google Scholar · View at Scopus
  122. D. J. Gelb, E. Oliver, and S. Gilman, “Diagnostic criteria for Parkinson disease,” Archives of Neurology, vol. 56, no. 1, pp. 33–39, 1999. View at Publisher · View at Google Scholar · View at Scopus
  123. P. Jenner, “Oxidative stress and Parkinson's disease,” Handbook of Clinical Neurology, vol. 83, pp. 507–520, 2007. View at Google Scholar
  124. J. Choi, M. C. Sullards, J. A. Olzmann et al., “Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases,” Journal of Biological Chemistry, vol. 281, no. 16, pp. 10816–10824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Y. Im, K. W. Lee, J. M. Woo, E. Junn, and M. M. Mouradian, “DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway,” Human Molecular Genetics, vol. 21, no. 13, pp. 3013–3024, 2012. View at Google Scholar
  126. C. M. Clements, R. S. McNally, B. J. Conti, T. W. Mak, and J. P.-Y. Ting, “DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15091–15096, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. C. Chavarria and J. M. Souza, “Oxidation and nitration of alpha-synuclein and their implications in neurodegenerative diseases,” Archives of Biochemistry and Biophysics, vol. 533, no. 1-2, pp. 25–32, 2013. View at Google Scholar
  128. V. N. Uversky, G. Yamin, P. O. Souillac, J. Goers, C. B. Glaser, and A. L. Fink, “Methionine oxidation inhibits fibrillation of human α-synuclein in vitro,” FEBS Letters, vol. 517, no. 1–3, pp. 239–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  129. R. Betarbet, T. B. Sherer, G. MacKenzie, M. Garcia-Osuna, A. V. Panov, and J. T. Greenamyre, “Chronic systemic pesticide exposure reproduces features of Parkinson's disease,” Nature Neuroscience, vol. 3, no. 12, pp. 1301–1306, 2000. View at Publisher · View at Google Scholar · View at Scopus
  130. M. Thiruchelvam, B. J. Brockel, E. K. Richfield, R. B. Baggs, and D. A. Cory-Slechta, “Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?” Brain Research, vol. 873, no. 2, pp. 225–234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Ramachandiran, J. M. Hansen, D. P. Jones, J. R. Richardson J.R., and G. W. Miller, “Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation,” Toxicological Sciences, vol. 95, no. 1, pp. 163–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. V. T. K. Chen, C.-L. Huang, Y.-C. Lee, W.-C. Liao, and N.-K. Huang, “The roles of the thioredoxin system and peroxiredoxins in 1-methyl-4-phenyl-pyridinium ion-induced cytotoxicity in rat pheochromocytoma cells,” Toxicology in Vitro, vol. 24, no. 6, pp. 1577–1583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. J. R. Roede, J. M. Hansen, Y.-M. Go, and D. P. Jones, “Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin/thioredoxin system,” Toxicological Sciences, vol. 121, no. 2, pp. 368–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  134. A. G. Estévez, N. Spear, J. Anthony Thompson et al., “Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor,” Journal of Neuroscience, vol. 18, no. 10, pp. 3708–3714, 1998. View at Google Scholar · View at Scopus
  135. G. Fujino, T. Noguchi, K. Takeda, and H. Ichijo, “Thioredoxin and protein kinases in redox signaling,” Seminars in Cancer Biology, vol. 16, no. 6, pp. 427–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. S. Karunakaran, L. Diwakar, U. Saeed et al., “Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α-lipoic acid,” The FASEB Journal, vol. 21, no. 9, pp. 2226–2236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. P. Jenner and C. W. Olanow, “Oxidative stress and the pathogenesis of Parkinson's disease,” Neurology, vol. 47, no. 6, supplement 3, pp. S161–S170, 1996. View at Google Scholar · View at Scopus
  138. P. Lopert, B. J. Day, and M. Patel, “Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells,” PLoS ONE, vol. 7, no. 11, Article ID e50683, 2012. View at Google Scholar
  139. M. S. Yoo, H. S. Chun, J. J. Son et al., “Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease,” Molecular Brain Research, vol. 110, no. 1, pp. 76–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  140. C. A. Ross and S. J. Tabrizi, “Huntington's disease: from molecular pathogenesis to clinical treatment,” The Lancet Neurology, vol. 10, no. 1, pp. 83–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. S. E. Browne, R. J. Ferrante, and M. F. Beal, “Oxidative stress in Huntington's disease,” Brain Pathology, vol. 9, no. 1, pp. 147–163, 1999. View at Google Scholar · View at Scopus
  142. F. Sánchez-López, I. Tasset, E. Agüera et al., “Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease,” Journal of Neurology Research, vol. 34, no. 7, pp. 721–724, 2012. View at Google Scholar
  143. D. Kapogiannis and M. P. Mattson, “Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease,” The Lancet Neurology, vol. 10, no. 2, pp. 187–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. X. Y. Zhang, D. C. Chen, M. H. Xiu et al., “The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients,” Schizophrenia Research, vol. 113, no. 2-3, pp. 151–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. B. Owe-Larsson, K. Ekdahl, T. Edbom et al., “Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 4, pp. 1117–1121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. X. Y. Zhang, C. Chen da, M. H. Xiu et al., “Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls,” Schizophrenia Research, vol. 143, no. 2-3, pp. 301–306, 2013. View at Google Scholar
  147. Y. Ogawa, H. Kosaka, T. Nakanishi et al., “Stability of mutant superoxide dismutase-1 associated with familial amyotrophic lateral sclerosis determines the manner of copper release and induction of thioredoxin in erythrocytes,” Biochemical and Biophysical Research Communications, vol. 241, no. 2, pp. 251–257, 1997. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Malaspina, N. Kaushik, and J. de Belleroche, “Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays,” Journal of Neurochemistry, vol. 77, no. 1, pp. 132–145, 2001. View at Publisher · View at Google Scholar · View at Scopus